Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride open-label study in schizophrenia and schizoaffective disorder
ACTRN12605000656639Phase 3Recruiting
- Sponsor
- Dr. Suresh Sundram
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of amisulpride in schizophrenia and schizoaffective disorder, sponsored by Dr. Suresh Sundram. Primary endpoint: Positive and Negative Syndrome Scale. Started Nov 2004; status: recruiting.
02
Drugs
amisulpride
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on ACTRN12605000656639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000656639.